Gemtuzumab ozogamicin in the treatment o
β
Francis Giles; Elihu Estey; Susan O'Brien
π
Article
π
2003
π
John Wiley and Sons
π
English
β 484 KB
π 2 views
## Abstract Gemtuzumab ozogamicin (GO) is a chemotherapeutic agent that consists of a humanized antiβCD33 antibody (hP67.6) linked to NβacetylβΞ³ calicheamicin 1,2βdimethyl hydrazine dichloride, a potent enediyne antitumor antibiotic. GO was approved conditionally by the Federal Drug Administration